Trial Profile
Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Endostatin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 27 Oct 2010 New trial record